Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

A tower crane has been installed for construction of the Wichita Biomedical Campus in downtown, marking the next significant ...

Ethan Grimes, BS, and Paul Morgan, MD, conduct rational drug design at the newly launched AI Small Molecule Drug Discovery Center at the Icahn School of Medicine at Mount Sinai. As part of Mount Sinai ...

The hiring freeze at the University of Washington threatens the research pipeline surging in the lab of Nobel Prize winner ...

New York City-based The Icahn School of Medicine at Mount Sinai has established a new research center focused on using AI to ...

For millions of years, frogs have flourished in microbial swamps yet rarely falling ill. To survive these hostile environments, they evolved potent chemical defenses. Now, scientists are learning to ...

A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes.

This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and ...

From designing the curriculum to recruiting faculty and students, building a medical school from the ground up is a unique ...

Blood loss is the leading cause of death in trauma patients between the ages of 1 and 46 years, largely because they cannot ...

Professors Joshua Leonard and Jonathan Rivnay are part of AIMBE’s College of Fellows Class of 2025, among the highest ...